Mitochondria serve as central hubs integrating various cellular functions, including lactate metabolism:
🏭 ⬆️ clearance may be due to enhanced NADH use
🏭 immune cells among most relevant sources of lactate in #sepsis
🏭 lactate associated with ⬇️ mitochondrial activity in skeletal muscle in sepsis
🏭 lactate biosynthesis in lymphocytes increase upon glycolytic demands, despite O2 availability Understanding lactate as metabolic product involving several phenomena & different organs makes it a biomarker indicative of prognosis/clinical response, more than therapeutic target. #FOAMcc on @yourICM
🔓 https://t.co/IPbPlOFWwT
Ethics of #ECLS, from beginning to present: balancing reasons, rather than deriving norms from facts...
Narrative review
➡️ethical impact of trials & evidence
➡️resource allocation, decision‑making, WLST
➡️defining death on #ECMO & #EISOR in DCD
@Crit_Care https://t.co/CfSG9mgKqZ
Insights into contact activation on #ECMO
FXII activity on run
⬇️at any timepoint in 98% of pts (may impair aPTT)
➡️median 30%
⬆️after weaning
⬇️is associated with ⬇️ thromboembolic complications: FXII as anticoagulation target?
@CritCareMed@MedUni_Wien https://t.co/B3LWVS9VRN
Felt so emotional today picking up my nurse uniform. I feel like I’ve waiting forever for this moment, to finally wear my blues 🥺👩⚕️ #NewlyQualifiedNurse#NQN
Might MV settings, lung mechanics, clinical data predict VV #ECMO weaning in severe #ARDS? Safe liberation (= no early need for re-cannulation/other rescue, ⬆️MV, nor hemodyn instability) less likely if
⬆️Vt
⬆️HR
⬆️VR
⬆️ΔPes
during SG off trial @accpchest https://t.co/LZGOJYTvwi
Post #COVID19 critical care in China, lessons & renaissance:
➡️resources (re)organization
➡️(judicious) use of antivirals/antibiotics
➡️clinical management
➡️PPE according to @WHO
➡️preventing #SARSCoV2 recurrence & coping with future outbreaks/#pandemics
https://t.co/tHsOoEIgVl
Very rarely Vaccine-associated Immune Thrombosis & Thrombocytopenia VITT has been reported: here successful early thromboaspiration + 12h intraportal fibrinolysis for extensive portomesenteric thrombosis, with full veins recanalization.
#COVID19#COVIDFOAM https://t.co/lErBMJnylj
#ECMO in #COVID19, comparing first vs second wave: increase in mortality vs weaning/survival: successful weaning in 58% vs 47%, overall survival 53% vs 44%. Time on ECMO appears longer in #SARSCoV2 pts: long runs(>28 days) & futile cases also increased. https://t.co/pzg3dVKi29
#ECMO for #COVID19: analysis of #ECLS provision during 1st/2nd waves from @EuroELSO EuroECMO survey indicate picture has changed: increased mortality vs weaning/survival. Conclusions premature, many bias & questions still requiring answer. @LancetRespirMed https://t.co/iIkaIKJ5Mw
'Matters of Time' is a thoughtful piece on those moments; seconds that last hours and hours that pass in seconds.
In #ICMfromtheinside this week, free read on @yourICM at https://t.co/9pAlgVMONN
Environmental sustainability of critical care
🌲contribution to carbon footprint
🌲how to get #ICU in order?
First? do not harm! Also maintaining healthy ecosystem & dissolving developed/developing countries disparities in ICM availability @KlimaGesundheit
https://t.co/HQdOmfItpd
VA #ECMO gap
🔸mortality 38% on #ECLS run, more than ⅓ of patients; most commonly due to MOF, cardiac failure, neuro causes
🔸15.3% mortality post-weaning: many successfully weaned pts decease during hospital stay
🔸44% discharged
@ArtifOrgans#FOAMecmo https://t.co/kzd8hRrXMk
Defining & understanding VA #ECMO gap, patients successfully weaned but eventually die during hospital stay: SR (1993 - 2020) including 60 studies & 9,181 patients aimed to investigate timing & causes of death in adults supported with VA ECMO. @ArtifOrgans
https://t.co/dbKIv6oVAZ
#TTM2
❄️targeted hypothermia 33°/controlled rewarming
vs
🌡️normothermia/early fever control BT ≥37.8°C
in pts with coma after #OHCA
NO ⬇️ death (6 months) 50 vs 48%
↔️ moderately severe disability or worse
⬆️arrhythmia resulting in hemodynamic compromise
https://t.co/a6ENPGaqsb